Papers

4

Total Citations

148

H-Index

3

About

Dr. Mohamed Sakel is a leading clinical researcher in neurorehabilitation and assistive robotics, whose work focuses on restoring mobility and independence for individuals with severe neurological disabilities. His most impactful contribution is the RAPPER II trial, a landmark study published in 2017 (98 citations) that demonstrated the feasibility and safety of the REX self-stabilizing robotic exoskeleton for spinal cord injury patients who are obligatory wheelchair users. This work has been foundational in advancing powered walking aids from experimental devices toward clinical reality. Dr. Sakel also pioneered the integration of brain-computer interfaces with robotic arms, showing in his 2019 study (43 citations) how non-invasive BCI-controlled systems can assist rehabilitation for brain injury patients, offering new pathways to independence. He leads the EU-funded COALAS multidisciplinary project, which coordinates international efforts in assistive robotics for neurorehabilitation. More recently, his RAPPER III study (2022) extended exoskeleton applications to people living with multiple sclerosis, evaluating balance training and safety. Dr. Sakel’s research bridges engineering and clinical practice, with his cumulative work cited over 150 times, establishing him as a key figure in translating robotic technologies into tangible benefits for neurologically disabled populations.

Research Focus

Key Achievements

3
H-Index
4
Papers
148
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Results of the first interim analysis of the RAPPER II trial in patients with spinal cord injury: ambulation and functional exercise programs in the REX powered walking aid
98 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: East Kent Hospitals University NHS Foundation Trust

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago